S100A9 and COVID-19: Regarding neutrophils, the increased expressions of CD177, IL1R2 and S100A9 in our study agree with the existing literature, which points towards the induction of a dysregulated neutrophil function in COVID-19 patients with increased NET production that aggravates the pathophysiology of COVID-19.